Showing results (101-110 of 720) with videos related to
Sort By:
Pageof 72
Combinatorial Chemistry & High Throughput Screening|December 18, 2020
Envisioning the Future of Nanomedicines in Management and Treatment of Neurological DisordersShobhit Kumar, Priyanka Singh, Shrestha Sharma, et al.International Journal of Biological Macromolecules|April 8, 2014
Donepezil nanosuspension intended for nose to brain targeting: In vitro and in vivo safety evaluationBhavna, Shadab Md, Mushir Ali, et al.Drug Delivery|March 28, 2014
Nanostructured lipid (NLCs) carriers as a bioavailability enhancement tool for oral administrationBharti Gaba, Mohammad Fazil, Asgar Ali, et al.International Journal of Pharmaceutics|May 10, 2011
Oil based nanocarrier for improved oral delivery of silymarin: In vitro and in vivo studiesRabea Parveen, Sanjula Baboota, Javed Ali, et al.Archives of Pharmacal Research|June 10, 2011
Effects of silymarin nanoemulsion against carbon tetrachloride-induced hepatic damageRabea Parveen, Sanjula Baboota, Javed Ali, et al.Drug Delivery|June 25, 2014
Brain targeting by intranasal drug delivery (INDD): a combined effect of trans-neural and para-neuronal pathwayGulam Mustafa, Abdulmohsen H Alrohaimi, Aseem Bhatnagar, et al.Current Protein & Peptide Science|October 7, 2020
Proteomic Analysis of Huntington's DiseaseShobhit Kumar, Priyanka Singh, Shrestha Sharma, et al.Drug Delivery|February 7, 2017
Nanocarriers as treatment modalities for hypertensionTausif Alam, Saba Khan, Bharti Gaba, et al.Journal of Pharmaceutical Sciences|August 5, 2018
Adaptation of Quality by Design-Based Development of Isradipine Nanostructured-Lipid Carrier and Its Evaluation for In Vitro Gut Permeation and In Vivo Solubilization FateTausif Alam, Saba Khan, Bharti Gaba, et al.Drug Delivery|October 10, 2013
Insights into direct nose to brain delivery: current status and future perspectiveDeepti Mittal, Asgar Ali, Shadab Md, et al.Pageof 72